HomeTarn Cancer Registry
Tarn Cancer Registry Profile Page
Tarn Cancer Registry

Contact Info

BP 37
Albi Cedex
France (metropolitan)
Dr. Pascale Grosclaude


Registration area

The Tarn Cancer Registry covers the department of Tarn in the Midi-Pyrénées region of southern France. The population is 362 000.

Cancer care facilities

The level of medical coverage in Tarn is relatively high. The department has five pathologists, two oncologists, two radiotherapists, four public hospitals, and four private clinics. Some cancer patients are referred to the university hospital or the regional cancer control centre, both located in Toulouse, the regional capital.

Registry structure and methods

The registry operates as a non-profit association. It is funded by the General Council of Tarn, the departmental committee of the French League Against Cancer, and the Institute for Public Health Surveillance. The registry staff consists of 11 people (7.5 full-time equivalents), who are responsible for both registration and research activities. Notifications are systematically checked and completed by consulting medical files. The data are coded by specially trained coders. The registry’s database is declared to the National Commission on Information Technology and Civil Liberties.

Interpreting the results

The apparent doubling of the observed incidence of bladder cancer in Tarn since the previous volume of Cancer Incidence in Five Continents is due to the inclusion of non-invasive bladder tumours in the data for this volume. The incidence rates of invasive tumours are relatively stable, at about 15 cases per 100 000 males and 2 cases per 100 000 females. The incidence of kidney cancer is increasing in France overall, and more rapidly in Tarn. This trend is assumed to be due to increased urological monitoring in men of this age, and to increased diagnosis after incidental discovery in women. The registry is involved in the European Randomized Study of Screening for Prostate Cancer; the first screening campaign in Tarn, in 2004, at least partly explains the observed increase in the incidence of prostate cancer in the area.

Use of the data

The registry performs a variety of studies, both independently and in collaboration with other registries. The topics investigated include cancer incidence, time trends, and prevalence, as well as diagnostic and therapeutic practices for cancers at selected sites.


This tab contains a basic no-frills image Gallery for CB profiles

No Items published in this profile gallery



Standard Tables

Our partners

120507 01b LOGO X3





This website was developed and is hosted at the International Agency for Research on Cancer (IARC)
Go to top